Congress slams US health officials on tainted drugs

November 15, 2012 by Jean-Louis Santini

US lawmakers slammed federal and state health officials Wednesday for failing to properly police a pharmacy whose tainted drugs caused a deadly fungal meningitis outbreak.

"This tragedy could have been avoided," said Congressman Cliff Stearns, who chairs the Energy and Commerce Committee's oversight and investigations panel.

The Florida Republican cited a litany of complaints against the New England Compounding Center and problems found during inspections over the past decade that were insufficiently investigated.

One such incident was when the received reports in 2002 that patients receiving NECC had experienced "adverse events," including "meningitis-like" symptoms.

"The product in question was the very same product connected to the current outbreak. In that case, the NECC drug was contaminated with bacteria," Stearns said.

While the FDA inspected NECC's Massachusetts facility in response to the complaints, that did not prevent more patients from getting sick from the same drugs six months later.

At a 2003 meeting with Massachusetts health officials—who hold primary responsibility for regulating pharmacies in their state—Stearns said the FDA made a "prophetic statement."

"The FDA stated that there was the potential for serious public health consequences if NECC's compounding practices, in particular those relating to sterile products, are not improved," Stearns said.

Some 461 people have been sickened—and 32 of them have died—after receiving injections of NECC's tainted steroids, according to the latest tally by the .

The outbreak has led to calls for tighter regulation of the loosely controlled pharmaceutical compounding industry. have launched a into the case.

"Even though FDA was clearly aware of the risks posed by NECC's compounding practices, the agency was slow to act," Stearns said.

It took the agency four years to issue a warning letter based on problems it found with NECC's sterility practices in 2002 and two more years for the FDA to respond to the company's claims challenging the report.

"When FDA finally responded in 2008—six years after the agency first inspected the NECC—it directed the company to correct the violations and warned that it would follow-up with future inspections. But FDA never did," Stearns said.

The FDA also failed to follow up after it received notification from the Colorado State Board of Pharmacy in 2011 that NECC was again violating the rules by sending its drugs to out-of-state hospitals without first receiving patient prescriptions.

And the Massachusetts Board of Pharmacy failed to correct problems at NECC despite receiving at least 12 separate complaints.

Critics say drug manufacturers have found a way to sidestep costly and strict oversight by classifying themselves as pharmacies, which are given freer rein to mix drug compounds for patients.

FDA Commissioner Margaret Hamburg told lawmakers that the agency lacked sufficient authority to regulate pharmacies that cross the line into mass production.

"FDA's ability to take action against compounding that exceeds the bounds of traditional pharmacy compounding and poses risks to patients has been hampered by gaps and ambiguities in the law," said Hamburg, who has led the agency since 2009.

These gaps in legal authority "have led to legal challenges to FDA's authority to inspect pharmacies and take appropriate enforcement actions," she told the panel.

NECC president Barry Cadden invoked the constitutional right to refuse to implicate himself as he declined to answer questions from the subcommittee, which did however hear testimony from a widow of one of the victims.

Explore further: US firm found mold long before shipping tainted drugs

Related Stories

US firm found mold long before shipping tainted drugs

October 27, 2012
A pharmacy tied to a meningitis outbreak repeatedly found bacteria and mold in its facility long before shipping tainted drugs to patients, US officials said Friday as the death toll rose to 25.

Problems at second US firm tied to meningitis outbreak

November 12, 2012
US federal health inspectors said Monday they have uncovered serious problems at a second Massachusetts pharmacy run by some of the same people whose tainted drugs caused a deadly meningitis outbreak.

Tests find bacteria in products of US pharmacy

November 2, 2012
Federal regulators said Thursday that they've found contamination in more drugs made by a pharmacy tied to a deadly meningitis outbreak.

US meningitis death toll rises to 30, officials say

November 5, 2012
The death toll from a meningitis outbreak linked to tainted drugs rose to 30 as the number of cases climbed to a whopping 419, US health officials said Monday.

US firm loses license as tainted drug toll rises to 24

October 25, 2012
US officials revoked the license Wednesday of a Massachusetts pharmacy cited for significant sanitary violations as the toll from a meningitis outbreak tied to its tainted drugs rose to 24.

FDA chief seeks new powers to police pharmacies

November 14, 2012
(AP)—The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.